Newsfeeds - Spark Newswire

2 minute read

Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday

Today, 10:02 PM

U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.

ALXO

1 minute read

Piper Sandler Maintains Overweight on Sutro Biopharma, Raises Price Target to $18

By Benzinga Newsdesk

Today, 10:02 PM

Piper Sandler analyst Edward Tenthoff maintains Sutro Biopharma (NASDAQ:STRO) with a Overweight and raises the price target from $16 to $18.

STRO

1 minute read

Sutro Biopharma Announces Update From STRO-002, Luveltamab Tazevibulin, Phase 1 Dose-Expansion Study And Registrational Plans In Advanced Ovarian Cancer

By Benzinga Newsdesk

Today, 10:02 PM

- Results from the STRO-002 (luvelta) Phase 1 dose-expansion study demonstrate that FolRα-selected patients experienced meaningful clinical benefit, with 43.8% ORR, median DOR of 5.4 months, and median PFS of 6.6

STRO

1 minute read

FDA
News

Watching Sutro Biopharma; Traders Circulate FDA Orphan Drug Designation For ‘Treatment of pediatric acute myeloid leukemia’

By Benzinga Newsdesk

Today, 10:02 PM

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=915722

STRO

1 minute read

Sutro Biopharma Q3 EPS $(0.37) Up From $(0.67) YoY

By Bill Haddad

Today, 10:02 PM

Sutro Biopharma (NASDAQ:STRO) reported quarterly losses of $(0.37) per share. This is a 44.78 percent increase over losses of $(0.67) per share from the same period last year.

STRO

2 minute read

Earnings

Sutro Biopharma Earnings Perspective: Return On Capital Employed

By Benzinga Insights

Today, 10:02 PM

According to data from Benzinga Pro, during Q2, Sutro Biopharma's (NASDAQ:STRO) reported sales totaled $28.10 million. Despite a 33.49% increase in earnings, the company posted a loss of $26.01 million.

STRO

1 minute read

Truist Securities Maintains Buy on Sutro Biopharma, Lowers Price Target to $21

By Benzinga Newsdesk

Today, 10:02 PM

Truist Securities analyst Asthika Goonewardene maintains Sutro Biopharma (NASDAQ:STRO) with a Buy and lowers the price target from $37 to $21.

STRO

1 minute read

Earnings

Recap: Sutro Biopharma Q2 Earnings

By Benzinga Insights

Today, 10:02 PM

Sutro Biopharma (NASDAQ:STRO) reported its Q2 earnings results on Monday, August 8, 2022 at 04:30 PM. Here's what investors need to know about the announcement.

STRO

4 minute read

InflaRx Climbs More Than 40%, Here’s 58 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:02 PM

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

ACIU

3 minute read

Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 10:02 PM

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

AGRX